Results 221 to 230 of about 14,908,548 (354)

Overcoming antigen tolerance to develop GB22-45-2, an anti-DKK1 antibody for gastric cancer. [PDF]

Antib Ther
Zhang W, Wei X, Yao T, Liang B, Yang X, Peng Y, Yin T, Dong W, Li H, Guo X, Qin S.   +10 more
europepmc   +1 more source

Developing socially responsible students : a thematic literature unit on social injustice [PDF]

, 2000
Tina White
openalex  

Developing and adapting church education program by smart problem-based learning

, 2014
남선우
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Advancing large-molecule discovery with a unified digital platform for data analysis and workflow management. [PDF]

MAbs
Natali E, Hersch J, Freiberg C, Steigele S.   +3 more
europepmc   +1 more source

Metabolic Syndrome as a Risk Factor for Developing Benign Prostatic Hyperplasia-A Simple, Non-invasive Method of Transabdominal Ultrasonography for BPH-

, 2006
Takashi Iizuka, Makiko Suzuki, Nana Minamiyama, Akemi Ando, Chie Kuramoto, Takeo Kuwabara, Kunio Yamaguchi   +6 more
openalex   +2 more sources

2017 Bench Memorandum [PDF]

, 2017

core   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

INSTRUCTIONAL DESIGN MODEL IN ORDER TO THE STEM EDUCATION FOR DEVELOPING STUDENT'S ACADEMIC ACHIEVEMENTS AND ATTITUDES TOWARD SCIENCE IN CHEMISTRY SUBJECT ON THE RATE OF CHEMICAL REACTION ISSUE OF SECONDARY STUDENTS AT THE 11TH GRADE LEVEL

, 2017
Tiptunya Duangsri, Panwilai Chomchid, Janpen Phusopha   +2 more
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source